Clinical TrialsSearch results
Number of results: 946
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- A phase II/III study of NPC-22
- chronic sialorrhea
- Miyoshi Katsunori
- 2024-06-14
Completed
- A Phase III Investigator Initiated Clinical Trial Evaluating the Efficacy and Safety of CNS7056 (Remimazolam) With a Concomitant Use of Opioid Analgesics in Japanese Patients Undergoing Gastrointestinal Endoscopy
- Japanese patients undergoing gastrointestinal endoscopy in combination with a concomitant use of opi
- Ikehara Hisatomo
- 2022-06-11
Completed
- A Phase III Long Term Study of K-877 Extended Release Tablet
- Dyslipidemia
- Tanigawa Ryohei
- 2021-02-05
Recruiting
- A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor low/HER2-negative Breast Cancer
- Breast Cancer
- Inoguchi Akihiro
- 2024-03-20
Other
- A phase III randomised trial of lobectomy versus limited resection (segmentectomy) for small (2 cm or less) peripheral non-small cell lung cancer (JCOG0802/WJOG4607L)
- small (2 cm or less) peripheral non-small cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2009-08-10
Other
- A Phase III Randomized, Multicenter Study Comparing Irinotevan and Cisplatin (IP) with Amrubicin and Cisplatin (AP) for the Treatment of Extensive-Stage Small-Cell Lung Cancer: (JCOG0509)
- extensive-disease small cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2007-05-22
Other
- A Phase III Study Comparing Etoposide and Cisplatin (EP) with Irinotecan and Cisplatin (IP) following EP plus Concurrent Accelerated Hyperfractionated Thoracic Irradiation (EP/TRT) for the Treatment of Limited-Stage Small-Cell Lung Cancer (EP/TRT-IPIII): JCOG0202-MF
- Limited-Stage Small-Cell Lung Cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- A Phase III Study Comparing Irinotecan, Cisplatin and Etoposide (PEI) with Nogitecan for the Treatment of Relapsed Small-Cell Lung Cancer (JCOG0605)
- Sensitive relpased small-cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2007-09-20
Completed
- A Phase III Study of ARS-1 Administration in Patients with Food Allegy
- Anaphylactic Symptoms Induced by An Oral Food Challenge Test
- Kenya Morita
- 2023-06-16
Other
- A Phase III Study of Consolidation Chemotherapy Using UFT plus Cisplatin versus Docetaxel Following Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
- Locally Advanced Non-Small Cell Lung Cancer
- The Tokyo Cooperative Oncology Group
- 2005-11-18